These results highlight the importance of evaluating the role of IFN activity within a tumor’s niche and are consistent with the findings that increased expression of IFNAR1 is associated with a poor prognosis in breast cancer patients [160]. This evidence concerns the gene IFNAR1 and breast cancer.